Quality Improvement and Pragmatic Research Jonathan Finkelstein, - - PowerPoint PPT Presentation

quality improvement and pragmatic
SMART_READER_LITE
LIVE PREVIEW

Quality Improvement and Pragmatic Research Jonathan Finkelstein, - - PowerPoint PPT Presentation

Oversight on the borderline: Quality Improvement and Pragmatic Research Jonathan Finkelstein, MD, MPH Vice Chair, Quality and Outcomes, Department of Medicine Boston Childrens Hospital Professor, Departments of Pediatrics and Population


slide-1
SLIDE 1

Oversight on the borderline: Quality Improvement and Pragmatic Research

Jonathan Finkelstein, MD, MPH Vice Chair, Quality and Outcomes, Department of Medicine Boston Children’s Hospital Professor, Departments of Pediatrics and Population Medicine Harvard Medical School

slide-2
SLIDE 2

I have no conflicts of interest to disclose.

slide-3
SLIDE 3
  • This presentation is based on the work of the QI and Pragmatic Trials

Workgroup of the NIH Collaboratory/ PCORnet Ethics and Regulatory Task Force

  • Oversight on the borderline: Quality improvement and pragmatic

research Clin Trials October 2015 12: 457-466, first published on September 15, 2015

  • Jonathan Finkelstein
  • Andrew Brickman
  • Alexander Capron
  • Daniel Ford
  • Adrijana Gombosev
  • Sarah Greene
  • R. Peter Iafrate
  • Laura Kolaczkowski
  • Sarah Pallin
  • Mark Pletcher
  • Karen Staman
  • Miguel Vazquez
  • Jeremy Sugarman
slide-4
SLIDE 4

A (very) brief history of human subjects oversight

  • 1974 National Research Act creates the National

Commission for Protection of Human Subjects of Biomedical and Behavioral Research

  • 1979 Belmont Report Released

– “statement of basic ethical principles and guidelines to assist in resolving research problems” – Respect for Persons – Beneficence – Justice

slide-5
SLIDE 5

Federal definitions

  • Research-a systematic investigation, including research

development, testing and evaluation, designed to develop

  • r contribute to generalizable knowledge
  • Human Subject - a living individual about whom an

investigator conducting research obtains: – data through intervention or interaction with the individual, or – identifiable private information

slide-6
SLIDE 6

Current oversight through implementation of the “Common Rule”

  • Assessment of Risks and Benefits

– Nature and scope, systematic assessment

  • Selection of Subjects
  • Elements of Informed Consent

– Information, comprehension, voluntariness

  • All under the Office of Human Research Protection, 45 CFR

Part 46, part A, (the Common Rule)

  • Special protections for children
slide-7
SLIDE 7

Contrast with “Healthcare Operations”…

slide-8
SLIDE 8

Contrast with “Healthcare Operations”…

  • Routine Healthcare operations do not require oversight as

human subjects research, but are regulated in many other ways by local, state, federal, and professional bodies.

slide-9
SLIDE 9

Contrast with “Healthcare Operations”…

  • Routine Healthcare operations do not require oversight as

human subjects research, but are regulated in many other ways by local, state, federal, and professional bodies.

  • Quality improvement activities are considered part of

routine operations.

slide-10
SLIDE 10

Current concern that the oversight regime requires updating

slide-11
SLIDE 11

Current concern that the oversight regime requires updating

  • Current research oversight system has generally worked

well in:

– Protecting patients from potential harm in research, particularly trials of experimental treatments – Maintaining voluntariness of participation (autonomy) – Protecting privacy

slide-12
SLIDE 12

Current concern that the oversight regime requires updating

  • Current research oversight system has generally worked

well in:

– Protecting patients from potential harm in research, particularly trials of experimental treatments – Maintaining voluntariness of participation (autonomy) – Protecting privacy

  • Has been less well suited to

– Research on health systems interventions at the level of clinicians, hospitals, and systems – Pragmatic research about existing clinical alternatives – QI related research

slide-13
SLIDE 13

Current concern that the oversight regime requires updating

  • Current research oversight system has generally worked

well in:

– Protecting patients from potential harm in research, particularly trials of experimental treatments – Maintaining voluntariness of participation (autonomy) – Protecting privacy

  • Has been less well suited to

– Research on health systems interventions at the level of clinicians, hospitals, and systems – Pragmatic research about existing clinical alternatives – QI related research

  • Major revision of the Common Rule now underway…
slide-14
SLIDE 14

What do we mean by Pragmatic Research, QI, and QI Research??

slide-15
SLIDE 15

What do we mean by Pragmatic Research, QI, and QI Research??

  • Pragmatic research- creation of generalizable knowledge

about relative effectiveness of alternative treatments or strategies, conducted in “real world” health care settings and designed to be maximally applicable under routine conditions.

slide-16
SLIDE 16

What do we mean by Pragmatic Research, QI, and QI Research??

  • Pragmatic research- creation of generalizable knowledge

about relative effectiveness of alternative treatments or strategies, conducted in “real world” health care settings and designed to be maximally applicable under routine conditions.

  • QI: “systemic data guided activities designed to bring

about immediate improvements in health care delivery in particular settings.” (Hastings Center Report 2004)

slide-17
SLIDE 17

What do we mean by Pragmatic Research, QI, and QI Research??

  • Pragmatic research- creation of generalizable knowledge

about relative effectiveness of alternative treatments or strategies, conducted in “real world” health care settings and designed to be maximally applicable under routine conditions.

  • QI: “systemic data guided activities designed to bring

about immediate improvements in health care delivery in particular settings.” (Hastings Center Report 2004)

  • QI Research: creation of generalizable knowledge about

methods for measuring and improving health care quality,

  • r that utilize quality improvement tools and strategies in

study design or intervention.

slide-18
SLIDE 18

Relation of QI and QI research

slide-19
SLIDE 19

Relation of QI and QI research

Research

slide-20
SLIDE 20

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery)

Relation of QI and QI research

Research

slide-21
SLIDE 21

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery) Knowledge of best alternatives in particular patients or setting

Relation of QI and QI research

Research

slide-22
SLIDE 22

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery) Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards

Relation of QI and QI research

Research

slide-23
SLIDE 23

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery) Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Relation of QI and QI research

Research

slide-24
SLIDE 24

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery) Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Relation of QI and QI research

Research QI Research

slide-25
SLIDE 25

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery) Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Accepted Clinical Standards

Relation of QI and QI research

Research QI Research

slide-26
SLIDE 26

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery) Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Accepted Clinical Standards Pragmatic Research on Health Care Delivery or QI Methods

Relation of QI and QI research

Research QI Research

slide-27
SLIDE 27

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery) Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Accepted Clinical Standards Pragmatic Research on Health Care Delivery or QI Methods Knowledge about best methods for bringing care in line with accepted standards

Relation of QI and QI research

Research QI Research

slide-28
SLIDE 28

Pragmatic Research on Clinical Alternatives (diagnostic, therapeutic, care delivery) Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Accepted Clinical Standards Pragmatic Research on Health Care Delivery or QI Methods Knowledge about best methods for bringing care in line with accepted standards

Relation of QI and QI research

Research QI Research

slide-29
SLIDE 29

Pragmatic Research on Clinical Alternatives Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Accepted Clinical Standards Pragmatic Research on Health Care Delivery or QI Methods Knowledge about best methods for bringing care in line with accepted standards

Relation of QI and QI research

Research QI Research

slide-30
SLIDE 30

Pragmatic Research on Clinical Alternatives Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Accepted Clinical Standards Pragmatic Research on Health Care Delivery or QI Methods Knowledge about best methods for bringing care in line with accepted standards

Relation of QI and QI research

Research QI Research

Implementation and spread using QI (and

  • ther methods)
slide-31
SLIDE 31

Pragmatic Research on Clinical Alternatives Knowledge of best alternatives in particular patients or setting Accepted Clinical Standards Implementation and spread using QI (and

  • ther methods)

Accepted Clinical Standards Pragmatic Research on Health Care Delivery or QI Methods Knowledge about best methods for bringing care in line with accepted standards Implementation and spread using QI (and

  • ther methods)

Knowledge about best methods for bringing care in line with accepted standards

Relation of QI and QI research

Research QI Research

slide-32
SLIDE 32

QI and Research: where do we draw the line

slide-33
SLIDE 33

QI and Research: where do we draw the line

  • When does “learning from data” become “seeking

generalizable knowledge”?

slide-34
SLIDE 34

QI and Research: where do we draw the line

  • When does “learning from data” become “seeking

generalizable knowledge”?

  • When does “measurement” become “systematic

collection”?

slide-35
SLIDE 35

QI and Research: where do we draw the line

  • When does “learning from data” become “seeking

generalizable knowledge”?

  • When does “measurement” become “systematic

collection”?

  • How do we think about “routine operations” in a Learning

Health System with “best practices seamlessly embedded in the delivery process and new knowledge captured as an integral by-product of the delivery experience”? (IOM Roundtable on Value and Science-driven Health Care)

slide-36
SLIDE 36

What’s special about QI research?

  • We are studying “meta” issues compared to direct

biological/clinical effect (though the interventions may have biological effects)

  • Potential harms generally different in both magnitude and

type.

  • Interventions often at the system level
  • Interventions could typically be implemented within

current care, often without measurement to assess whether they worked.

  • How care is mediated by clinician-patient relationship and

health systems structures

slide-37
SLIDE 37

Ethical Issues in a learning health care system: Hastings Center Report 2013

  • Lines between system

learning and research.

  • Role of the IRB or other
  • versight.
  • Issues of consent in system

level tests of change.

  • Ensuring patient privacy in a

digital, learning system

slide-38
SLIDE 38

Ethical Issues in a learning health care system: Hastings Center Report 2013

  • Lines between system

learning and research.

  • Role of the IRB or other
  • versight.
  • Issues of consent in system

level tests of change.

  • Ensuring patient privacy in a

digital, learning system

slide-39
SLIDE 39

The research-treatment dichotomy

  • Kass and Faden1 question core tenets of the distinction:

– Generalizable knowledge as the criterion for ethical

  • versight
  • “In a learning health care environment, practice is a

continuous source of data for the production of generalizable knowledge, and the the knowledge that is produced is used to continuously change and improve practice.” – “Systematic data collection” is now part of practice – Research may or may not present less clinical benefit

  • r increased burden/risk

1Kass NE et al. Hastings Center Report 2013

slide-40
SLIDE 40

A risk-based framework?

  • Working group of the IOM Roundtable on Value and

Science Driven Health Care proposes a framework of

  • versight based primarily on risk.

Information-only Minimal Greater th

  • perations
  • ther

Risk

institutional oversight no IRB oversight no consent needed IRB oversight consent requirement determined by IRB HIPPA research standards

1Selker H et al. The Common rule and continuous

  • improvement. IOM 2012
slide-41
SLIDE 41

QI and Pragmatic Trials Workgroup of the NIH Collaboratory PCORnet Ethics and Regulatory Task Force

Oversight on the borderline: Quality improvement and pragmatic research Clin Trials October 2015 12: 457-466, first published on September 15, 2015

slide-42
SLIDE 42

QI and Pragmatic Trials Workgroup of the NIH Collaboratory PCORnet Ethics and Regulatory Task Force

  • Multi-stakeholder perspective

– Researcher – Clinician – Legal/Ethics – Patient

Oversight on the borderline: Quality improvement and pragmatic research Clin Trials October 2015 12: 457-466, first published on September 15, 2015

slide-43
SLIDE 43

QI and Pragmatic Trials Workgroup of the NIH Collaboratory PCORnet Ethics and Regulatory Task Force

  • Multi-stakeholder perspective

– Researcher – Clinician – Legal/Ethics – Patient

  • Overarching premise: all activities related to health care

must occur in a framework of oversight that addresses ethical principles.

Oversight on the borderline: Quality improvement and pragmatic research Clin Trials October 2015 12: 457-466, first published on September 15, 2015

slide-44
SLIDE 44

Two questions addressed by the workgroup:

  • What QI activities should have explicit ethical oversight in
  • rder to help ensure adherence to fundamental ethical

principles of health care?

  • Are there special considerations in the oversight of

pragmatic QI research activities that optimally protect patients and other participants yet allow for rapid system learning?

slide-45
SLIDE 45

Attaching names is challenging…

slide-46
SLIDE 46

Attaching names is challenging…

  • Differentiation of activities for appropriate
  • versight

– Routine QI – Non-Routine QI – QI Research

slide-47
SLIDE 47

Attaching names is challenging…

  • Differentiation of activities for appropriate
  • versight

– Routine QI – Non-Routine QI – QI Research

  • Who decides which category applies?
slide-48
SLIDE 48

Attaching names is challenging…

  • Differentiation of activities for appropriate
  • versight

– Routine QI – Non-Routine QI – QI Research

  • Who decides which category applies?
  • Who provides ethical oversight?
slide-49
SLIDE 49

Criteria for consideration of projects (no bright line test)

  • Purpose
  • Sponsorship and leadership
  • Locus of control of intervention/clinical decisions
  • Ability of individuals to opt out
  • Data analysis/monitoring
  • Dissemination plan
  • Expected application of findings
  • Accountability and regulatory issues
  • Stakeholder engagement
slide-50
SLIDE 50

Routine QI

  • A Children’s Hospital identified that 35% of the time

patients with asthma were discharged with a written asthma treatment plan that included all 7 elements as required by The Joint Commission – A multidisciplinary team convened to define set roles, responsibilities for improving this process – Data was collected monthly and reported to team and

  • versight committee

– PDSA cycles run to test different strategies for improvement – The team was interested in presenting their work at various regional and national meetings Courtesy D. Hyman, MD

slide-51
SLIDE 51

Routine QI: oversight by clinical program leadership

  • Are interventions to promote standard or established

care?

  • Does the project further the goals of the clinical

leadership and team?

  • Are there additional risks to patients because the project

is underway?

  • Are data collection burdens consistent with what is

expected in routine care and organizational improvement?

  • Are there additional privacy concerns?
slide-52
SLIDE 52

Intent to publish as a criterion? No.

  • The Office for Human Research Protections (OHRP), states

“intent to publish is an insufficient criterion for determining whether a quality improvement activity involves research.”

  • Other health systems may learn from QI approaches, even

if the project has not answered a specific research question.

  • However, such dissemination must be described as a QI

activity, and not make claims of new knowledge generation using typical standards of clinical or health services research.

www.hhs.gov/ohrp/policy/faq/quality-improvement-activities/intent-to-publish.html

slide-53
SLIDE 53

Non- routine QI

slide-54
SLIDE 54

Non- routine QI

  • The Emergency Departments of 20 hospitals convene as a

to improve “door to balloon time” for patients with suspected ST-elevation myocardial infarction.

slide-55
SLIDE 55

Non- routine QI

  • The Emergency Departments of 20 hospitals convene as a

to improve “door to balloon time” for patients with suspected ST-elevation myocardial infarction.

  • They create a menu of system-level interventions, all of

which represent standard care at some of the existing programs.

slide-56
SLIDE 56

Non- routine QI

  • The Emergency Departments of 20 hospitals convene as a

to improve “door to balloon time” for patients with suspected ST-elevation myocardial infarction.

  • They create a menu of system-level interventions, all of

which represent standard care at some of the existing programs.

  • Each participating program chooses which interventions to

implement in rapid cycle tests of change (PDSA cycles).

slide-57
SLIDE 57

Non- routine QI

  • The Emergency Departments of 20 hospitals convene as a

to improve “door to balloon time” for patients with suspected ST-elevation myocardial infarction.

  • They create a menu of system-level interventions, all of

which represent standard care at some of the existing programs.

  • Each participating program chooses which interventions to

implement in rapid cycle tests of change (PDSA cycles).

  • All agree to track and share outcomes measures

(deidentified) with all other sites.

slide-58
SLIDE 58

Non- routine QI

  • The Emergency Departments of 20 hospitals convene as a

to improve “door to balloon time” for patients with suspected ST-elevation myocardial infarction.

  • They create a menu of system-level interventions, all of

which represent standard care at some of the existing programs.

  • Each participating program chooses which interventions to

implement in rapid cycle tests of change (PDSA cycles).

  • All agree to track and share outcomes measures

(deidentified) with all other sites.

  • There is intent to share (through publication of a “quality

report”) what works best in specific settings.

slide-59
SLIDE 59

Non-routine QI (a proposal): Formal oversight by health care organizations

slide-60
SLIDE 60

Non-routine QI (a proposal): Formal oversight by health care organizations

  • Might be best under the aegis of a body specifically

constituted for oversight of non-routine QI.

– Include QI experts, clinicians, system leaders – Stakeholder representatives (e.g. patients)

slide-61
SLIDE 61

Non-routine QI (a proposal): Formal oversight by health care organizations

  • Might be best under the aegis of a body specifically

constituted for oversight of non-routine QI.

– Include QI experts, clinicians, system leaders – Stakeholder representatives (e.g. patients)

  • Would serve to “register” such projects internally and

encourage consistency, transparency, and reporting of results.

slide-62
SLIDE 62

Non-routine QI (a proposal): Formal oversight by health care organizations

  • Might be best under the aegis of a body specifically

constituted for oversight of non-routine QI.

– Include QI experts, clinicians, system leaders – Stakeholder representatives (e.g. patients)

  • Would serve to “register” such projects internally and

encourage consistency, transparency, and reporting of results.

  • May also require notification of patients in the health care

system (rather than formal consent).

slide-63
SLIDE 63

Non-routine QI (a proposal): Formal oversight by health care organizations

  • Might be best under the aegis of a body specifically

constituted for oversight of non-routine QI.

– Include QI experts, clinicians, system leaders – Stakeholder representatives (e.g. patients)

  • Would serve to “register” such projects internally and

encourage consistency, transparency, and reporting of results.

  • May also require notification of patients in the health care

system (rather than formal consent).

  • IRB’s may take on this role but may not have the expertise

in all areas.

slide-64
SLIDE 64

Would any of the following always make this research?

slide-65
SLIDE 65

Would any of the following always make this research?

  • A group of hospitals who agreed to continue to

provide usual care?

slide-66
SLIDE 66

Would any of the following always make this research?

  • A group of hospitals who agreed to continue to

provide usual care?

  • The hospitals agreeing to be randomly assigned

an intervention to implement as a PDSA cycle?

slide-67
SLIDE 67

Would any of the following always make this research?

  • A group of hospitals who agreed to continue to

provide usual care?

  • The hospitals agreeing to be randomly assigned

an intervention to implement as a PDSA cycle?

  • A stepped wedge design in which the groups

decide together on a single bundle of interventions and implement them at defined time points so that comparison groups exist?

slide-68
SLIDE 68

Would any of the following always make this research?

  • A group of hospitals who agreed to continue to

provide usual care?

  • The hospitals agreeing to be randomly assigned

an intervention to implement as a PDSA cycle?

  • A stepped wedge design in which the groups

decide together on a single bundle of interventions and implement them at defined time points so that comparison groups exist?

  • A design in which patients are randomized (by day
  • f week) to receive the “improvement”?
slide-69
SLIDE 69

QI Research Example

www.nihcollaboratory.org/demonstration-projects/Pages/ICD-Pieces.aspx

slide-70
SLIDE 70

QI Research Example

  • Improving Chronic Disease Management with Pieces (ICD-

Pieces) trial

www.nihcollaboratory.org/demonstration-projects/Pages/ICD-Pieces.aspx

slide-71
SLIDE 71

QI Research Example

  • Improving Chronic Disease Management with Pieces (ICD-

Pieces) trial

  • Tests a novel technology that leverages data from EHR’s to

identify patients with chronic kidney disease, diabetes, and hypertension, and provides clinician support to monitor therapies and measure outcomes.

www.nihcollaboratory.org/demonstration-projects/Pages/ICD-Pieces.aspx

slide-72
SLIDE 72

QI Research Example

  • Improving Chronic Disease Management with Pieces (ICD-

Pieces) trial

  • Tests a novel technology that leverages data from EHR’s to

identify patients with chronic kidney disease, diabetes, and hypertension, and provides clinician support to monitor therapies and measure outcomes.

  • Research question: does incorporating new IT facilitate

collaborative care.

www.nihcollaboratory.org/demonstration-projects/Pages/ICD-Pieces.aspx

slide-73
SLIDE 73

Oversight: IRB

  • Tests system level change.
  • Designed to provide generalizable knowledge about

average effect, across many contexts.

  • Robust number of participants and measurement strategy

designed to determine results with certainty typical of health services research.

  • Funded as research.
slide-74
SLIDE 74

Our conclusions

Oversight on the borderline: Quality improvement and pragmatic research Clin Trials October 2015 12: 457-466

slide-75
SLIDE 75

Our conclusions

  • 1. Health care organizations should have systematic,

transparent processes for designating activities as QI or research and determining what independent evaluation each will receive.

Oversight on the borderline: Quality improvement and pragmatic research Clin Trials October 2015 12: 457-466

slide-76
SLIDE 76

Our conclusions

  • 1. Health care organizations should have systematic,

transparent processes for designating activities as QI or research and determining what independent evaluation each will receive.

  • 2. Health care organizations should have formal and

explicit oversight of Non-QI activities.

Oversight on the borderline: Quality improvement and pragmatic research Clin Trials October 2015 12: 457-466

slide-77
SLIDE 77

Our conclusions

  • 1. Health care organizations should have systematic,

transparent processes for designating activities as QI or research and determining what independent evaluation each will receive.

  • 2. Health care organizations should have formal and

explicit oversight of QI activities.

  • 3. QI-related research should be reviewed by an IRB; for

such review to be effective, IRB’s should develop particular expertise in assessing QI studies.

Oversight on the borderline: Quality improvement and pragmatic research Clin Trials October 2015 12: 457-466

slide-78
SLIDE 78

Our conclusions

  • 1. Health care organizations should have systematic,

transparent processes for designating activities as QI or research and determining what independent evaluation each will receive.

  • 2. Health care organizations should have formal and

explicit oversight of QI activities.

  • 3. QI-related research should be reviewed by an IRB; for

such review to be effective, IRB’s should develop particular expertise in assessing QI studies.

  • 4. Stakeholder engagement should be included in the

review of QI and QI-related research proposals and implementation

Oversight on the borderline: Quality improvement and pragmatic research Clin Trials October 2015 12: 457-466

slide-79
SLIDE 79

We live in the real world: current guidance from OHRP

  • QI does not need IRB review. Research does. QI includes:

– Implementing a practice to improve the quality of care – Collecting patient or provider data regarding implementation for “clinical, practical, or administrative uses.”

1See http://answers.hhs.gov/ohrp/questions/7290

slide-80
SLIDE 80

We live in the real world: current guidance from OHRP

  • QI does not need IRB review. Research does. QI includes:

– Implementing a practice to improve the quality of care – Collecting patient or provider data regarding implementation for “clinical, practical, or administrative uses.”

  • Intent to publish is an insufficient criterion to determine if

something is research (and intent not to publish does not preclude research).

1See http://answers.hhs.gov/ohrp/questions/7290

slide-81
SLIDE 81

We live in the real world: current guidance from OHRP

  • QI does not need IRB review. Research does. QI includes:

– Implementing a practice to improve the quality of care – Collecting patient or provider data regarding implementation for “clinical, practical, or administrative uses.”

  • Intent to publish is an insufficient criterion to determine if

something is research (and intent not to publish does not preclude research).

  • Human subjects research definition per HHS applies to

pragmatic trials as well

1See http://answers.hhs.gov/ohrp/questions/7290

slide-82
SLIDE 82

We live in the real world: current guidance from OHRP

  • QI does not need IRB review. Research does. QI includes:

– Implementing a practice to improve the quality of care – Collecting patient or provider data regarding implementation for “clinical, practical, or administrative uses.”

  • Intent to publish is an insufficient criterion to determine if

something is research (and intent not to publish does not preclude research).

  • Human subjects research definition per HHS applies to

pragmatic trials as well

  • Minimal risk research can receive expedited review (not

exemption).

1See http://answers.hhs.gov/ohrp/questions/7290

slide-83
SLIDE 83

Notice of Proposed Rule Making (NPRM) to Modernize the Common Rule (9/8/15)

  • By HHS and 15 federal agencies
  • Followed an Advanced Notice of Proposed Rule

– Exclusions for activities that are not research, are low risk, or covered by other protections – New process for exemption without IRB review – Requirement for a single IRB for multi-center studies – Extend scope to cover all clinical trials (regardless of funding source) at any institution that receives federal funding

slide-84
SLIDE 84

New exclusion for QI activities: we may have a problem

  • The exclusion for QI 101(b)(1)(iv) currently states:

101(b)(1)(iv) “Quality assurance or improvement activities involving the implementation of an accepted practice to improve the delivery or quality of care or services (including, but not limited to, education, training, and changing procedures related to care or services) if the purposes are limited to altering the utilization of the accepted practice and collecting data or biospecimens to evaluate the effects on the utilization of the practice.”

Federal Register / Vol. 80, No. 173 / Tuesday, September 8, 2015 / Proposed Rules

slide-85
SLIDE 85

Summary

slide-86
SLIDE 86

Summary

  • QI as part of health care operations does not require IRB
  • versight, but still may require oversight.
slide-87
SLIDE 87

Summary

  • QI as part of health care operations does not require IRB
  • versight, but still may require oversight.
  • The current definitions and requirements were not

designed with current types of pragmatic QI-research in mind- and causes difficulties in the evolution of an efficient, learning health care system.

slide-88
SLIDE 88

Summary

  • QI as part of health care operations does not require IRB
  • versight, but still may require oversight.
  • The current definitions and requirements were not

designed with current types of pragmatic QI-research in mind- and causes difficulties in the evolution of an efficient, learning health care system.

  • We are responsible for acting within current regulations

and facilitating the evolution within our institutions and nationally of improved processes.

slide-89
SLIDE 89

Summary

  • QI as part of health care operations does not require IRB
  • versight, but still may require oversight.
  • The current definitions and requirements were not

designed with current types of pragmatic QI-research in mind- and causes difficulties in the evolution of an efficient, learning health care system.

  • We are responsible for acting within current regulations

and facilitating the evolution within our institutions and nationally of improved processes.

  • Awaiting the revision of the Common Rule…
slide-90
SLIDE 90

Summary

  • QI as part of health care operations does not require IRB
  • versight, but still may require oversight.
  • The current definitions and requirements were not

designed with current types of pragmatic QI-research in mind- and causes difficulties in the evolution of an efficient, learning health care system.

  • We are responsible for acting within current regulations

and facilitating the evolution within our institutions and nationally of improved processes.

  • Awaiting the revision of the Common Rule…
  • (Spoiler alert: it won’t solve all of the issues.)
slide-91
SLIDE 91

The floor is open…